98%
921
2 minutes
20
Unlabelled: Bacterial persistence increases therapy duration, disease relapse, and antibiotic resistance. Mechanisms underlying persistence and feasible ways to rapidly eliminate persister cells are largely unknown. The present work examined genetic and environmental perturbations to identify anti-death events occurring in persister and phenotypically tolerant cells. The quiescent status of and persister cells, which were protected from killing by multiple antibiotics, was insensitive to the presence/absence of exogenous nutrients. In contrast, stationary-phase and nutrient-starved wild-type cultures, which displayed tolerance rather than the subpopulation status of persistence, were readily killed by ciprofloxacin upon restoration of nutrients, thereby indicating that tolerance was phenotypic. Both persistent and tolerant cells suppressed accumulation of reactive oxygen species (ROS), DNA breakage, and global metabolic activity. Restoration of nutrients to stationary-phase cultures restored these three processes for phenotypically tolerant cells but not for persister cells. Cultures of high-frequency-persistent and mutants and low-frequency-persistent wild-type cells were rapidly sterilized by ROS-independent, synergistic membrane disruption using aminoglycoside-polymyxin combinations; rapid eradication occurred at clinically achievable concentrations for both antibiotics. The aminoglycoside-polymyxin combination also killed environmentally tolerant cells but more slowly. The combination killed both laboratory and clinical isolates of gram-negative bacteria, an mutant that is pan-tolerant to diverse antibiotics and disinfectants, and cells in a biofilm model. Moderate lethality was observed with the gram-positive bacterium . The work indicates that suppression of ROS accumulation is a common feature of persistence and phenotypic tolerance, and it emphasizes ROS-independent strategies for controlling quiescent bacterial populations.
Importance: The report generalizes the concept that persistence and tolerance involve suppression of toxic metabolites (reactive oxygen species [ROS]). The work also shows that an environmental perturbation (nutrient deprivation) leads to antibiotic tolerance rather than persistence, thereby raising questions about the classification of other environmental perturbations. The synergistic action of multiple aminoglycoside species with polymyxins opens many treatment options. Lethality with biofilms and with may extend polymyxin-based therapies beyond planktonic, gram-negative bacteria, and the ROS independence of the combination may allow antioxidant mitigation of drug toxicity. Overall, the work advances our knowledge of persistent and tolerant bacterial pathogens and our efforts to eradicate them.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12345145 | PMC |
http://dx.doi.org/10.1128/mbio.01199-25 | DOI Listing |
Nat Rev Immunol
September 2025
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Actin cytoskeleton remodelling drives the migration of immune cells and their engagement in dynamic cell-cell contacts. The importance of actin cytoskeleton dynamics in immune cell function is highlighted by the discovery of inborn errors of immunity (IEIs) that are caused by defects in individual actin-regulatory proteins, resulting in immune-related actinopathies. In addition to susceptibility to infection, these often present with a vast array of autoimmune and autoinflammatory manifestations.
View Article and Find Full Text PDFTrends Immunol
September 2025
Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 10 Center Drive, 12N248C, Bethesda, MD 20892, USA. Electronic address:
Autoimmune diseases arise from genetic and environmental factors that disrupt immune tolerance. Recent studies highlight the role of myeloid cell immunometabolism, particularly mitochondrial dysfunction, in driving autoimmunity. Mitochondria regulate energy homeostasis and cell fate; their impairment leads to defective immune cell differentiation, abnormal effector activity, and chronic inflammation.
View Article and Find Full Text PDFNeurotherapeutics
September 2025
RWJMS Institute for Neurological Therapeutics and Department of Neurology, Rutgers-Robert Wood Johnson Medical School, Piscataway NJ08854, USA. Electronic address:
Eur J Pharmacol
September 2025
Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China. Electronic address:
Type 1 diabetes mellitus (T1DM) is an autoimmune disorder in which autoantibodies cause the immune system to attack and destroy pancreatic β-cells, leading to insufficient insulin production and impaired blood glucose control. T follicular helper (Tfh) cells are recognized as a group of CD4 T cells that help B cells to produce high-affinity antibodies. Our previous research found that oxymatrine (OMT) exhibits excellent immunomodulatory properties on Tfh cells in autoimmune diseases.
View Article and Find Full Text PDFJ Reprod Immunol
September 2025
Division of Pharmacology and Toxicology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh 243122, India. Electronic address:
Pregnancy demands dynamic immune adaptations to support implantation, fetal growth, and labor while maintaining maternal-fetal tolerance. The immune profile shifts from pro-inflammatory during implantation to anti-inflammatory in mid-pregnancy, reverting to inflammation at labor onset. Key immune cells like NK cells, macrophages, dendritic cells, and T cells dominate the decidua, guiding successful placental development.
View Article and Find Full Text PDF